Article Details
Retrieved on: 2023-01-08 17:51:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibody treatment lemanecab has been observed to reduce Ab plaques in clinical trials and recently received FDA approval for its ...
Article found on: theprint.in
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here